Back to Search
Start Over
902: UTILITY OF APIXABAN OR RIVAROXABAN ANTI-XA LEVELS IN TRANSITIONING PATIENTS TO HEPARIN INFUSIONS.
- Source :
-
Critical Care Medicine . 2022 Supplement, Vol. 50, p447-447. 1p. - Publication Year :
- 2022
-
Abstract
- B Introduction/Hypothesis: b Activated partial thromboplastin times and heparin-calibrated anti-Xa levels are used to monitor unfractionated heparin infusions. B Results: b Fifty-nine patients were included in each study group with similar baseline characteristics, except for the higher utilization of an increased bleeding risk heparin infusion protocol in the evaluation group (23.7% vs 6.8%; p=0.01). [Extracted from the article]
- Subjects :
- *HEPARIN
*APIXABAN
*RIVAROXABAN
Subjects
Details
- Language :
- English
- ISSN :
- 00903493
- Volume :
- 50
- Database :
- Academic Search Index
- Journal :
- Critical Care Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 154197607
- Full Text :
- https://doi.org/10.1097/01.ccm.0000809932.66896.2e